In the fourth part of the Harm Reduction episode, we focus on the work of the Community Liver Alliance, a non-profit organization serving the community in Pittsburgh, Pennsylvania through disease awareness, prevention, education, advocacy and research.
Join Suzanna Masartis, CEO of Community Liver Alliance, as she shares her organization’s groundbreaking work to build community capacity and leadership around harm reduction.
For more information about Community Liver Alliance, visit:
Website: communityliveralliance.org/
Facebook: / communityliveralliance
Twitter: / cliveralliance
For more information about Gilead, visit:
Website: www.gilead.com
Stories@Gilead: stories.gilead.com
Twitter: / gileadsciences
LinkedIn: / gileadsc. .
Instagram: / gileadsciences
Facebook: / gileadsciences
About Gilead
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
This webinar episode was created and fully funded by Gilead Sciences, Inc. GILEAD, the GILEAD logo, and the & design are trademarks of Gilead Sciences, Inc. © 2023 Gilead Sciences, Inc. All rights reserved.